3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
6
Carcinoma, Non-Small-Cell Lung
4
Rectal Neoplasms
2
Oropharyngeal Neoplasms
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Brain Neoplasms
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Squamous Cell Carcinoma of Head and Neck
1
Smoldering Multiple Myeloma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pleuropulmonary blastoma
1
Pelvic Neoplasms
1
Papillary Thyroid Microcarcinoma
1
Pancreatic Neuroendocrine Tumors (pNET)
1
Non-Muscle Invasive Bladder Neoplasms
1
Neuroblastoma
1
Neoplasms
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Meningioma
1
Interventions
Etoposide
3
Carboplatin
3
pembrolizumab
2
fludarabine phosphate
2
fludarabine
2
Paclitaxel
2
Cyclophosphamide
2
Cisplatin
2
repotrectinib
1
pralsetinib
1
lutetium Lu 177 dotatate
1
Vorinostat
1
Standard of Care
1
Specimen Handling
1
Respiratory Physiological Phenomena
1
Practice Guidelines as Topic
1
Platinum
1
Pemetrexed
1
Nivolumab
1
Mesna
1
Magnetic Resonance Spectroscopy
1
Immunotherapy
1
Ifosfamide
1
Gemcitabine
1
Cytapheresis
1
Bleomycin
1
Biopsy
1
Automobiles
1
130-nm albumin-bound paclitaxel
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms, Germ Cell and Embryonal
×
Watchful Waiting
×
90 days
×
Clear all
No trials found.